SCHEMBL2970547

SCHEMBL2970547

COC(=O)C1CSC2CC(NC(=O)OC(C)(C)C)(c3ccccc3)C(=O)N21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
MMP2 P08253 2/20 0.35
KMT2A Q03164 3/20 0.34
DPP4 P27487 2/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
KLK5 Q9Y337 1/20 0.34
ANPEP P15144 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
GFER P55789 1/20 0.33
CYP2C9 P11712 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CASP1 P29466 1/20 0.31
PPIA P62937 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13205166 1.00 CYP2C19 (0.37) CYP2C19CYP1A2MMP2KMT2ADPP4
SCHEMBL2983373 0.91 DPP4 (0.39) KMT2ADPP4DPP8DPP9DDB1
SCHEMBL13205162 0.91 DPP4 (0.39) KMT2ADPP4DPP8DPP9DDB1
SCHEMBL13223326 0.85 DPP8 (0.35) KMT2ADPP4ALDH1A1DPP8DPP9
SCHEMBL2987216 0.83 DPP4 (0.54) DPP4
SCHEMBL13205164 0.83 DPP4 (0.54) DPP4
SCHEMBL6479943 0.82 PPIA (0.40) CYP2C19CYP1A2MMP2KMT2ADPP4
SCHEMBL5346028 0.78 CYP2C19 (0.37) CYP2C19CYP1A2MMP2KMT2ADPP4
SCHEMBL8294822 0.78 PPIA (0.31) DPP8DPP9PPIA
SCHEMBL6474079 0.75 DPP4 (0.35) DPP4GFERPPIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786163-B2 Constrained cyano compounds Forest Laboratories Holdings Limited (BM) 2010-08-31 US disclosed
US-20060009518-A1 Constrained cyano compounds Forest Laboratories Holding Limited (BM) 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009518-A1 Constrained cyano compounds DNPEP, PREP, PEPD CYP2C19 1961/4885CYP1A2 2953/4885MMP2 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.